Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 432-130-2 | CAS number: 119345-01-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Expert statement: CAS 119345-01-6 has a minor potential for bioaccumulation. The relevant absorption rates can be estimated by expert judgement to 20% (oral), 10% (dermal) and 25% (inhalation).
Key value for chemical safety assessment
- Bioaccumulation potential:
- low bioaccumulation potential
- Absorption rate - oral (%):
- 20
- Absorption rate - dermal (%):
- 10
- Absorption rate - inhalation (%):
- 25
Additional information
In order to assess the toxicokinetic behaviour of CAS 119345-01-6, the available toxicological and physico-chemical data as well as QSAR estimations were evaluated.
The substance, i.e. the unchanged parent compounds, is expected to be rather poorly absorbed via the oral route. With a molecular weight of > 500 g/mol, absorption in general can be considered as hindered. However, taking into account the Log Pow > 6, a hindered absorption e.g. by diffusion is indicated, and also, only water-soluble substances will readily dissolve into the gastrointestinal fluids and hence be available for absorption, which limits the absorption of the rather insoluble compound. The presence of absorption could also not be proven by any effects observed in animal studies. In consequence, only a minor absorption rate needs to be assumed, i.e. approx. 20%.
CAS 119345-01-6 has a very low vapour pressure and decomposes at 260-280°C before boiling, showing that the inhalative absorption as a gas does not have to be regarded, which is supported by the fact that it is solid at room temperature. However, the substance is commonly distributed in powder form. In case of accidental exposure the inhalation of particles so has to be regarded. Approx. 89% of the particles are <100 µm (inhalable fraction), ~ 40% are <10 µm (thoracic fraction), and ~19% are < 4µm (respirable fraction). Hence, a relevant proportion may reach the alveolar region, where no mechanical excretion mechanism as the ciliary movements is available. Due to the high logPow > 6, and its insolubility in water, immediate absorption by micellular solubilisation has to be assumed,butCAS 119345-01-6 does not fulfil the criteria of being perfectly absorbed via the lungs, hence,a precautionary absorption rate of up to 25% can be estimated, as its insolubility limits the further distribution via blood.
In case of CAS 119345-01-6, neither evaporation after skin contact nor very remarkable additional absorption-enhancing effects due to corrosivity need to be regarded. Taking into account the high molecular weight, high Log Pow and very low water solubility, a passage of the compound through all layers of the skin is unlikely. So, only a minor absorption rate of 10% needs to be taken into account.
Taking into account the molecular weight of > 500 g/mol (594.82 - 1035.44g/mol of the single constituents), the very lipophilic character and poor water solubility, the absolute systemic bioavailability is rather low and expected to be more extensive in fat tissues than in other tissues. As, after first pass metabolism if any, more hydrophilic metabolites are expected to occur, and a rather minor absorption of CAS 119345-01-6, no relevant peak exposure, AUC and prolonged bioavailability will occur.
Since CAS 119345-01-6 is not considered to be absorbed very well, extensive accumulation is not expected. After metabolism, the excretion of the metabolites, either as such or after Phase 2 metabolism, will occur faster than the parent compounds. The sites of metabolism of the all parent compounds were identified as the aromatic rings, aromatic hydroxylation is the most likely scenario for Phase-I-metabolism. It is most likely that the substance of interest will be subject to metabolism by cytochrome P450 enzymes and subsequent conjugation.
In conclusion, CAS 119345-01-6 has a minor potential for bioaccumulation in its non-metabolised form as absorption is hindered, and will be excreted accompanying / subsequent metabolism.
The present expert statement covers all relevant toxicokinetic parameters to assess the behaviour of CAS 119345-01-6 in the body, the available information is well-investigated and sufficient to enable one to perform a proper risk assessment. The tonnage-driven data requirement under REACH are fully met and hence, no further information needs to be gathered and further studies can be omitted due to animal welfare.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.